Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 36-42

  Moreno, Olga ^a   González, Clara Isabel ^a   Saaibi, Diego Luis ^b   Otero, William ^a   Badillo, Reynaldo ^a   Martín, Javier ^c   Ramírez, Gerardo ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b Clínica Carlos Ardila Lulle   (Spain)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Genetic predisposition; Interleukin 4; Rheumatoid arthritis

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN M; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; RECEPTOR SUBUNIT; RHEUMATOID FACTOR;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IMMUNOGENETICS; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COLOMBIA; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RHEUMATOID FACTOR;

EID: 33846231479     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Silman AJ, Pearson J. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002;4 Suppl 3:S265-S272.
2. Nepom GT. The role of the DR4 shared epitope in selection and commitment of autoreactive T cells in rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:305-15.
3. Newton JL, Harney SMJ, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004;5:151-7.
4. Deighton CM, Walter DJ, Griffiths ID, Robertos DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
5. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
6. Firestein GS. Evolving concepts of rheumathoid arthritis. Nature 2003;423:356-61.
7. Smith JB, Haynes MK. Rheumatoid arthritis. A molecular understanding. Ann Intern Med 2002;36:908-22.
8. Nelms K, Keegan A, Zamorano J, Ryan J, Paul W. The IL-4-receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 1999;17:701-38.
9. Morita Y, Yamamura M, Kawashima M, et al. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflamatory cytokine production and fibroblast proliferation in rheumatoid synovium. Rheumatol Int 2001;20:49-54.
10. Miossec P, Navilliat M, Dupuy d'Angeac VJ, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of trasforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990;33:1180-7.
11. Cantagrel A, Navaux F, Loubet-Lescoulié P, et al. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4 and interleukin-10 gene polymorphisms. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
12. Deichmann K, Bardutsky J, Forster J, Heinzmann A, Kuehr J. Common polymorphisms in the coding part of the IL-4 receptor gene. Biochem Biophys Res Commun 1997;231:696-7.
13. Mitsuyasu H, Izuhara K, Mao X-Q, et al. DeSOVa1 variant of IL-4R upregulates IfE synthesis and associates with atopic asthma. Nature Genetics 1998;19:119-20.
14. Lubberts E, Joosten LAB, Chabaud M, et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 2000;105:1697-710.
15. Boyle DL, Nguyen KHY, Zhuang S, et al. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2 activity. Gene Ther 1999;6:1911-8.
16. Yoshino S. Effects of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice. Br J Pharmacol 1988;123:237-42.
17. Van der Hosch F, Russel A, Keystone EC, et al. rHUIL-4 in subjects with active rheumatoid arthritis: a phase I dose escalating safety study [abstract]. Arthritis Rheum 1998;41 Suppl:S56.
18. Gerli R, Bistoni O, Russano A, et al. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 2002;129:549-55.
19. Raza K, Falciani F, Curnow SJ, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-R795.
20. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
21. Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
23. Noguchi E, Shibasaki M, Arinami T, et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998;28:449-53.
24. Noguchi E, Shibasaki M, Arinami T, et al. No association between atopy/asthma and the ile50val polymorphism of IL-4 receptor. Am J Respir Crit Care Med 1999;160:342-5.
25. Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocytes immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin 13 receptor gene: the dichotomy of extrinsin and intrinsic atopic dermatitis. J Invest Dermatol 2002;119:870-5.
26. Mujica-Lopez KI, Florez-Martínez SE, Ramos-Zepeda R, et al. Association analysis of polymorphisms in the interleukin-4 receptor gene with atopic asthma in patients from western Mexico. Eur J Immunogenet 2002;29:375-8.
27. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JAH, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000;85:1984-8.
28. Emery AEH. Methodology in medical genetics. An introduction to statistical methods. London: Churchill Livingstone; 1976:3-10.
29. Daniel WW. Bioestadística. Base para el análisis de las ciencias de la salud. 4th ed. Mexico City: Limusa Wiley DF; 2002:571-657.
30. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-21.
31. Weyand CM, Goronzy JJ. Pathomechanisms in rheumatoid arthritis - time for a string theory? J Clin Invest 2006;116:869-71.
32. Abbas AK, Murphy KM, Sher A. Functional diversity of helper lymphocytes. Nature 1996;383:787.
33. Hochrein H, O'Keeffe M, Luft T, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 2000;192:823-33.
34. Yao Y, Li W, Kaplan MH, Chang CH. Interleukin (IL)-4 inhibits IL-IO to promote IL-12 production by dendritic cells. J Exp Med 2005;201:1899-903.
35. Biederman T, Himmelrich H, Gumy A, et al. IL-4 instructs TH1 responses and resistance to Leishmaniasis major in susceptible BALB/c mice. Nat Immunol 2001;2:1054-60.
36. Gregory GD, Raju SS, Winandy S, Brown MA. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 2006;116:1327-36.
37. Edwards CJ, Cooper C. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 2006;143:1-5.
38. Simpson CR, Anderson WJ, Helms PJ, et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002;32:37-42.
39. Maksymowych WP, Suarez-Almazor M, Buenviaje H, et al. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J Rheumatol 2002;29:2319-26.
40. Pawlik A, Wrzesniewska J, Florezak M, Ostanek L, Gawronska B, Herczynska M. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 2005;26:48-51.
41. Rosenwasser LJ. Structure/function variants as candidates genes in asthma: linkage vs association for relevance. Clin Exp Allergy 1998;28Suppl 1:90-2.
42. Kawashima T, Noguchi E, Arinami T, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998;35:502-4.
43. Inoue T, Kira R, Nakao F, et al. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002;59:822-7.
44. Relic B, Guicheux J, Mezin F, et al. IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 2001;166:2775-82.
45. Salmon M, Pilling D, Borthwick NJ, Akbar AN. Inhibition of T cell apoptosis: a mechanism for persistence in chronic inflammation. The Immunologist 1997;5:87-92.
46. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-92.
47. Parsonage G, Falciani F, Burman A, et al. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost 2003;90:688-97.
48. Chen Y, Rosloniec E, Goral MJ, Boothby M, Chen J. Redirection of T cell IL-2Rβ/IL-4Ra chimeric cytokine receptor transgene. J Immunol 2001;166:4163-9.
49. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Thl/Th2 cytokine patterns and the arthritogenic response in collagen induced arthritis. Eur J Immunol 1996;26:1511-8.
50. Schimmer RC, Schrier DJ, Flory CM, et al. Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-γ, and monocyte chemoattractant protein 1. J Immunol 1998;160:1466-71.
51. Hirano T. Revival of, the autoantibody model in rheumatoid arthritis. Nature Immunol 2002;3:342-4.
52. Ohmura K, Nguyen LT, Locksley RM, Mathis D, Benoist C. Interleukin-4 can be a positive regulator of inflammatory arthritis. Arthritis Rheum 2005;52:1866-75.
53. Aarvak T, Chabaud M, Thoen J, Miossec P, Natvig JB. Changes in the Th1 or Th2 cytokine dominance in the synovium of rheumatoid arthritis (RA): a kinetic study of the Th subsets in one unusual RA patient. Rheumatology Oxford 2000;39:513-22.
54. Saaibi DL. Factor reumatoideo ý otros auotanticuerpos en artritis reumatoide. In: Ramírez LA, Anaya J-M, editors. Artritis reumatoide. 2 ed. Bogotá: Editorial Edimeco SA; 2004:117-25.
55. Bukhari M, Lunt M, Harrison BJ, Scott DGI, Symmons DPM, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Arthritis Rheum 2002;46:906-12.
56. Markus M, Nielen J, van Schaardenburg D, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheumatism 2004;50:380-6.
57. Stephenson L, Johns MH, Woodward E, Mora AL, Boothby M. An IL-4Ra allelic variant, 150, acts as a gain-of-function variant relative to V50 for STAT6, but not Th2 differentiation. J Immunol 2004;173:4523-8.
58. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. New Engl J Med 1997;337:1720-5.